Scarica l'app Stockscreener
217.99
7.10%
-16.65
Dopo l'orario di chiusura:
217.99
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AXSM Giù?
Forum
Previsione
Precedente Chiudi:
$234.64
Aprire:
$234.46
Volume 24 ore:
781.96K
Relative Volume:
0.86
Capitalizzazione di mercato:
$11.22B
Reddito:
$708.24M
Utile/perdita netta:
$-188.30M
Rapporto P/E:
-58.30
EPS:
-3.7392
Flusso di cassa netto:
$-70.99M
1 W Prestazione:
-9.55%
1M Prestazione:
-10.94%
6M Prestazione:
+18.31%
1 anno Prestazione:
+115.02%
Intervallo 1D:
$217.64
$235.10
Intervallo di 1 settimana:
$217.64
$245.50
Portata 52W:
$96.09
$260.19
Axsome Therapeutics Inc Stock (AXSM) Company Profile
Nome
Axsome Therapeutics Inc
Settore
Industria
Telefono
(212) 332-3241
Indirizzo
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Compare AXSM vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AXSM
Axsome Therapeutics Inc
|
217.99 | 12.27B | 708.24M | -188.30M | -70.99M | -3.7392 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-24 | Iniziato | Wolfe Research | Outperform |
| 2026-01-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-01 | Iniziato | B. Riley Securities | Buy |
| 2025-09-03 | Ripresa | Wells Fargo | Overweight |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-03 | Iniziato | Oppenheimer | Outperform |
| 2025-04-07 | Iniziato | Jefferies | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-12-31 | Reiterato | Mizuho | Outperform |
| 2024-09-03 | Iniziato | Wells Fargo | Overweight |
| 2024-08-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-07-22 | Iniziato | Needham | Buy |
| 2024-04-29 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-03-19 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2024-01-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-12-13 | Iniziato | Citigroup | Buy |
| 2023-08-08 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-01-05 | Iniziato | Piper Sandler | Neutral |
| 2022-11-01 | Iniziato | Loop Capital | Buy |
| 2022-09-07 | Ripresa | Mizuho | Buy |
| 2021-08-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-10 | Iniziato | Berenberg | Buy |
| 2021-01-08 | Iniziato | Jefferies | Buy |
| 2020-12-16 | Iniziato | Mizuho | Buy |
| 2020-09-29 | Iniziato | BofA Securities | Underperform |
| 2020-09-10 | Iniziato | Morgan Stanley | Overweight |
| 2020-04-28 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-14 | Iniziato | Cowen | Outperform |
| 2019-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2019-12-17 | Reiterato | H.C. Wainwright | Buy |
| 2019-12-16 | Reiterato | Guggenheim | Buy |
| 2019-10-16 | Iniziato | Guggenheim | Buy |
| 2019-09-18 | Iniziato | William Blair | Outperform |
| 2019-05-28 | Iniziato | SunTrust | Buy |
| 2019-05-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-04-08 | Iniziato | SVB Leerink | Outperform |
| 2019-03-15 | Reiterato | H.C. Wainwright | Buy |
| 2016-10-03 | Ripresa | Brean Capital | Buy |
| 2015-12-15 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-12-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Axsome Therapeutics Inc Borsa (AXSM) Ultime notizie
Axsome Therapeutics Inc (AXSM) Balance Sheet - TradingKey
Healthcare of Ontario Pension Plan Trust Fund Invests $16.49 Million in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Inc (AXSM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BlackRock, Inc. (AXSM) reports 2.74M Axsome Therapeutics shares in Schedule 13G/A - Stock Titan
Axsome Therapeutics, Inc. Revenue Breakdown – TRADEGATE:19X - TradingView
Axsome Therapeutics Inc (AXSM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Axsome Therapeutics, Inc. $AXSM Shares Sold by Orbimed Advisors LLC - MarketBeat
Axsome Therapeutics Inc (AXSM) Institutional Confidence - TradingKey
Axsome Therapeutics Inc (AXSM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Axsome Therapeutics, Inc. (AXSM): Investor Outlook on a Biotech Trailblazer with a 17% Upside Potential - DirectorsTalk Interviews
AXSM Stock Is Rising Today After Wall Street’s Positive Stance Despite Mixed Q1 – What's Behind The Optimism? - Stocktwits
Caxton Associates LLP Makes New Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
AXSM|Axsome Therapeutics Inc|Price:241.000|Chg%:-0.530 - TradingKey
Axsome Therapeutics Inc (AXSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bank of New York Mellon Corp Cuts Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Inc (AXSM) Income Statement - TradingKey
California Public Employees Retirement System Makes New Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Inc. (AXSM) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Axsome Therapeutics Inc. (AXSM) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Axsome Therapeutics Inc. (AXSM) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Axsome Therapeutics Inc. (AXSM) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Axsome Therapeutics Inc. (AXSM) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Axsome Therapeutics’ Q4 Numbers Beat Wall Street Expectations: Analyst Sees Over 23% Upside For Stock - Stocktwits
Axsome Therapeutics Inc. (AXSM) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Axsome Therapeutics, Inc. (AXSM) stock price, news, quote and history - Yahoo Finance UK
Axsome Therapeutics, Inc. (AXSM) Stock Price, News, Quote & History - Yahoo! Finance Canada
First Trust Advisors LP Increases Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. Revenue Breakdown – NASDAQ:AXSM - TradingView
Axsome Therapeutics Inc. (AXSM) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
AXSM Stock In Spotlight Ahead Of Key FDA Verdict On Alzheimer’s Drug This Week - Stocktwits
Axsome Therapeutics (AXSM) Stock is Attractive on the Back of its Key Drug - Yahoo Finance
Illinois Municipal Retirement Fund Invests $884,000 in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Inc (AXSM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
68,453 Shares in Axsome Therapeutics, Inc. $AXSM Acquired by Hsbc Holdings PLC - MarketBeat
AXSOME THERAPEUTICS INC : LEERINK PARTNERS RAISES TARGET PRICE TO $265 FROM $250 - webull.com
AXSOME THERAPEUTICS INC : BMO INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $310 - webull.com
Axsome Therapeutics (NASDAQ:AXSM) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) Upgraded to "Strong-Buy" at BMO Capital Markets - MarketBeat
AXSM Initiated Coverage by BMO Capital -- Outperform Rating Assi - GuruFocus
BMO Capital Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $310 - Moomoo
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
BMO Capital Initiates Axsome Therapeutics at Outperform With $310 Price Target - marketscreener.com
Fifth Third Bancorp Has $2.74 Million Stock Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
BMO Capital Initiates Axsome Therapeutics(AXSM.US) With Buy Rating, Announces Target Price $310 - Moomoo
Axsome gains as narcolepsy therapy undergoes FDA review - MSN
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Axsome Therapeutics, Inc. $AXSM Stock Holdings Reduced by Principal Financial Group Inc. - MarketBeat
5 Best Biotech Stocks for 2026 and How to Invest - The Motley Fool
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Harmony Biosciences Holdings (HRMY) and Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Responsive Playbooks and the AXSM Inflection - Stock Traders Daily
Axsome Therapeutics Inc Azioni (AXSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Axsome Therapeutics Inc Azioni (AXSM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| TABUTEAU HERRIOT | Chief Executive Officer |
Jul 01 '26 |
Sale |
240.25 |
49,666 |
11,932,256 |
7,229 |
2.44%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):